AI in Life Science Analytics Market Outlook:
AI in Life Science Analytics Market size was valued at USD 2.36 billion in 2025 and is expected to reach USD 8.98 billion by 2035, registering around 14.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of AI in life science analytics is evaluated at USD 2.66 billion.
AI-driven analytics are booming the life science sector by offering accurate and reliable data interpretation which further aids in drug discovery and clinical trials. The integration of life science tools with natural language processing and automation is gaining traction across the world.
Cloud-based solutions are anticipated to exhibit high demand throughout the forecasted period and capture a revenue share of 55.5% through 2037. Cloud’s flexibility, cost-effectiveness, and scalability are the prime pointers driving their adoption among end users. Many cloud-based solutions offer access to several advanced AI tools and platforms that accelerate development in life science. Also, several modern cloud-based solutions are enabled with advanced security features and compliance certifications, which help life science organizations protect vital data and meet regulatory requirements. For instance, in 2023, Google Cloud revealed the launch of next-gen AI-powered life sciences solutions Target and Lead Identification Suite and Multiomics Suite. These solutions are aiding scientists in identifying the function of amino acids more effectively and in discovering and interpreting genomic data for personalized treatment.
